RecruitingNCT06983847

A Long-term Observational Study to Describe the Use of Vitamin-C Injektopas® 7.5 g in Patients With Vitamin C Deficiency

Observational Study on Vitamin C-Injektopas® 7.5g in Patients With Vitamin C Deficiency Due to Acute and Chronic Diseases


Sponsor

Pascoe Pharmazeutische Praeparate GmbH

Enrollment

1,000 participants

Start Date

Jan 12, 2019

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to learn more about the disease and the symptoms where the product will use and in which patient groups. Further on, it is interesting to know clinical pictures, the symptoms improve. Patients with acute or chronical disease with vitamin c deficiency could be involved. The main questions it aims to answer are: * how do the symptoms of the disease change * how is the tolerability


Eligibility

Min Age: 18 YearsMax Age: 120 Years

Inclusion Criteria2

  • Patients with vitamin C deficiency
  • Age ≥ 18 years

Exclusion Criteria6

  • Hypersensitivity to the active ingredient or any of the excipients
  • Oxalate urolithiasis
  • Iron storage disease (thalassemia, hemochromatosis, sideroblastic anemia) or recent red blood cell transfusion
  • Renal insufficiency
  • Glucose-6-phosphate dehydrogenase deficiency/defect
  • Pregnant/breastfeeding women

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Multiple Physicians from Austria

Vienna, Etc., Austria, Austria

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06983847


Related Trials